Applied Health Economics and Health Policy

Papers
(The TQCC of Applied Health Economics and Health Policy is 6. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-12-01 to 2025-12-01.)
ArticleCitations
Cost-Effectiveness of Perinatal Depression Screening: A Scoping Review151
Cost-Effectiveness and Value of Information Analyses of Caplacizumab for the Treatment of Thrombotic Thrombocytopenic Purpura in Brazil77
Therapy, Pills and Unmet Needs for Financial Reasons: Socioeconomic Inequalities and Inequities in Access to Mental Health Care in Spain 2014–202040
Cost-Effectiveness of a Universal School-Based Mental Health Prevention Program: An Economic Modeling Study in a Limited Income Context38
Cost-Effectiveness Analysis of Evolocumab or Inclisiran in Combination with Statins Versus Statin Monotherapy Among Patients with ASCVD in China34
Which Factors are Holding up the Integration of the Environmental Impact of Health Technologies in Health Technology Assessment? Insights from a Multi-Stakeholder Interview Study33
Assessing the Direct Impact of Death on Discrete Choice Experiment Utilities32
Population Norms for SF-6Dv2 and EQ-5D-5L in China29
Approaches to Incorporation of Preferences into Health Economic Models of Genomic Medicine: A Critical Interpretive Synthesis and Conceptual Framework28
Cost-Effective and Sustainable Drug Use in Hospitals: A Systematic and Practice-Based Approach28
Deterministic and Probabilistic Analysis of a Simple Markov Model: How Different Could They Be?23
Economic Evaluation of Evusheld for Preexposure Prevention of COVID-19 in High-Risk Populations: Early Evidence from Thailand23
Psychometric Evaluation of the PedsQL GCS and CHU9D in Australian Children and Adolescents with Common Chronic Health Conditions23
Applications of Behavioral Economics to Pharmaceutical Policymaking: A Scoping Review with Implications for Best-Value Biological Medicines23
The Economics of Antibiotic Resistance: A Systematic Review and Meta-analysis Based on Global Research23
Selection and Prioritization of Medical Devices for HTA Evaluation: A Systematic Review of Existing Approaches21
A Guideline-Implementation Intervention to Improve the Management of Low Back Pain in Primary Care: A Difference-in-Difference-in-Differences Analysis21
Exploratory Approach to Incorporating Carbon Footprint in Health Technology Assessment (HTA) Modelling: Cost-Effectiveness Analysis of Health Interventions in the United Kingdom21
Correction to: Cost Effectiveness of Allogeneic Umbilical Cord Blood-Derived Mesenchymal Stem Cells in Patients with Knee Osteoarthritis20
Local Level Economic Evaluation: What is it? What is its Value? Is it Sustainable?20
10 Years of AMNOG: What is the Willingness-to-Pay for Pharmaceuticals in Germany?18
A Systematic Review of the World’s Largest Government Sponsored Health Insurance Scheme for 500 Million Beneficiaries in India: Pradhan Mantri Jan Arogya Yojana18
How is Value Defined in Molecular Testing in Cancer? A Scoping Review17
Economic Evaluation Evidence for Resource-Allocation Decision Making: Bridging the Gap for Local Decision Makers Using English Case Studies16
Financing Comprehensive Immunization Services in Lao PDR: A Fiscal Space Analysis From a Public Policy Perspective16
Correction: Deterministic and Probabilistic Analysis of a Simple Markov Model: How Different Could They Be?15
The Economic Cost of Rising Non-communicable Diseases in India: A Systematic Literature Review of Methods and Estimates15
Scope Issue in Contingent Valuation Studies of the COVID-19 Vaccine: The Case of China14
Including Pharmaceuticals in Bundled Payments14
Estimating the Health Effects of Expansions in Health Expenditure in Indonesia: A Dynamic Panel Data Approach13
Development of a Health Technology Assessment Quality Appraisal Checklist (HTA-QAC) for India12
Contextual Factors that Influence Antibiotic Prescribing: A Discrete Choice Experiment of GP Registrars12
Economic Effects of Fixed-Dose Versus Loose-Dose Combination Therapy for Type 2 Diabetes Patients12
Valuation of Costs in Health Economics During Financial and Economic Crises: A Case Study from Lebanon12
How Much Should be Invested in Lung Care Across the WHO European Region? Applying a Monetary Value to Disability-Adjusted Life-Years Within the International Respiratory Coalition’s Lung Facts12
The Impact of Unrelated Future Medical Costs on Economic Evaluation Outcomes for Different Models of Diabetes12
Social Costs of Smoking in the Czech Republic12
Guiding Health Resource Allocation: Using Population Net Health Benefit to Align Disease Burden with Cost Effectiveness for Informed Decision Making11
Measures of Performance and Clinical Superiority Thresholds for ‘Test-and-treat’ Predictive Biomarkers11
Cost-Effectiveness and Budget Impact Analysis of Implementing a 'Soft Opt-Out' System for Kidney Donation in Australia11
Correction to: Different Frameworks, Similar Results? Head-to-Head Comparison of the Generic Preference-Based Health-Outcome Measures CS-Base and EQ-5D-5L11
Is Economic Evaluation and Care Commissioning Focused on Achieving the Same Outcomes? Resource-Allocation Considerations and Challenges Using England as a Case Study11
Supply-Side Cost-Effectiveness Thresholds: Questions for Evidence-Based Policy10
Trump’s Drug Pricing Order and the Domestic Economic Trade-Off10
Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) Statement: Updated Reporting Guidance for Health Economic Evaluations10
Projected Impact on Labour Productivity Costs of Cancer-Related Premature Mortality in Europe 2018–204010
A Systematic Review of Cost-Effectiveness Analyses of Colorectal Cancer Screening in Europe: Have Studies Included Optimal Screening Intensities?10
Does the Choice of Health Metric, DALY or QALY, Influence Conclusions of Health Economic Evaluation? A Case Study of Rotavirus Vaccine in Burundi10
Herd Immunity Effects in Cost-Effectiveness Analyses among Low- and Middle-Income Countries9
Machine Learning-Assisted Health Economics and Policy Reviews: A Comparative Assessment9
Young People’s Preferences for Web-Based Mental Health Interventions for Managing Anxiety and Depression: A Discrete Choice Experiment9
Effect of Competition on Generic Drug Prices9
Cost-Effectiveness of Anti-retroviral Adherence Interventions for People Living with HIV: A Systematic Review of Decision Analytical Models9
Value and Price of Multi-indication Cancer Drugs in the USA, Germany, France, England, Canada, Australia, and Scotland9
Mechanisms Considering Public Investment in Pricing and Reimbursement Decisions of Medicines and Other Health Technologies: A Scoping Review9
The Effects of School Closures on COVID-19: A Cross-Country Panel Analysis8
Productivity Loss and Indirect Costs for Patients Newly Diagnosed with Early- versus Late-Stage Cancer in the USA: A Large-Scale Observational Research Study8
Information Asymmetry in Hospitals: Evidence of the Lack of Cost Awareness in Clinicians8
The Health Economics of Genomic Technologies: A Growing Evidence Base on Value8
Forecasting the Incremental Value to Society Created by a Class of New Prescription Drugs: A Proposed Methodology and Its Application to Treating Chronic Hepatitis C in India8
Comparing Preferences for Disease Profiles: A Discrete Choice Experiment from a US Societal Perspective8
Sedaconda ACD-S for Sedation with Volatile Anaesthetics in Intensive Care: A NICE Medical Technologies Guidance8
Cost-Effectiveness of Once-Weekly Semaglutide 1 mg versus Canagliflozin 300 mg in Patients with Type 2 Diabetes Mellitus in a Canadian Setting8
Analysing the Efficiency of Health Systems: A Systematic Review of the Literature8
Willingness to Pay for National Health Insurance: A Contingent Valuation Study Among Patients Visiting Public Hospitals in Melaka, Malaysia8
Use of Cost-Effectiveness Thresholds in Healthcare Public Policy: Progress and Challenges8
The Broader Opportunity Costs in the Broader Cost-Effectiveness Analysis Framework8
Measurement of Catastrophic Health Expenditure in India: A Systematic Review and Meta-Analysis8
Societal Cost of Racial Pneumococcal Disease Disparities in US Adults Aged 50 Years or Older8
Headroom Analysis for Early Economic Evaluation: A Systematic Review7
The Limitations and Potentials of Evaluating Economic Aspects of Community-Based Health Promotion: A Critical Review7
Cost-effectiveness Analysis of the Dental RECUR Pragmatic Randomized Controlled Trial: Evaluating a Goal-oriented Talking Intervention to Prevent Reoccurrence of Dental Caries in Children7
A Head-On Comparison of EQ-VT- and Crosswalk-Based EQ-5D-5L Value Sets7
Using Genomic Heterogeneity to Inform Therapeutic Decisions for Metastatic Colorectal Cancer: An Application of the Value of Heterogeneity Framework7
A Systematic Review of Economic Evaluations on Interventions Targeting Insomnia or Hypersomnia7
Discrete Event Simulation in R using the ‘Simmer’ Package for Health Economic Modelling: A Tutorial and Illustration in Colon Cancer7
EQ-5D-5L Population Norms for Italy7
Estimating a Drug’s Price After Loss of Exclusivity as a Function of Its Cost of Goods Sold7
Estimated Carbon Savings from Changing Surgical Trends in Primary Elective Total Hip Arthroplasty in England: A Retrospective Observational Study6
The Impact of Value-Based Payment Models for Networks of Care and Transmural Care: A Systematic Literature Review6
Preferences for Digital Mental Health Services in Urban China: A Discrete Choice Experiment6
Exploring Consumer Preferences for Cannabis Vaping Products to Support Public Health Policy: A Discrete Choice Experiment6
A Systematic Review of Health Economic Evaluations and Budget Impact Analyses to Inform Healthcare Decision-Making in Central America6
Health Reform in Aotearoa New Zealand: Insights on Health Equity Challenges One Year On6
Use of Decision-Analytic Modelling to Assess the Cost-Effectiveness of Diagnostic Imaging of the Spine, Shoulder, and Knee: A Scoping Review6
Model-Based Economic Evaluations of Interventions for Dementia: An Updated Systematic Review and Quality Assessment6
Acknowledgement to Referees6
Modelled Distributional Cost-Effectiveness Analysis of Childhood Obesity Interventions: A Demonstration6
0.97403597831726